Article begins on next page

Similar documents
Article begins on next page

Article begins on next page

Article begins on next page

Article begins on next page

Female Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan

Article begins on next page

Article begins on next page

2-Hypertrichosis:- Hypertrichosis is the

Evaluation of Ovarian Lesions Inducing Endometrial Hyperplasia or Carcinoma in a Tertiary Care Hospital in Southern India

Article begins on next page

Article begins on next page

Endometrial line thickness in different conditions.

Case Report Bilateral Sclerosing Stromal Ovarian Tumor in an Adolescent

Article begins on next page

Case Report Ovarian Leydig Cell Hyperplasia: An Unusual Case of Virilization in a Postmenopausal Woman

Article begins on next page

Polycystic ovarian disease and Endometriosis

5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe

Prof.Dr. Nabil Lymon Head of Internal Medicine Department

SAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:

Case Report An Interesting Cause of Hyperandrogenemic Hirsutism

REI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

Article begins on next page

Endometrial Stromal Tumors

Polycystic Ovarian Syndrome (PCOS) LOGO

Papers in Press. Published August 1, 2018 as doi: /clinchem

One Day Hormone Check

Case. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?

Hormone. Free Androgen Index. 2-Hydroxyestrone. Reference Range. Hormone. Estrone Ratio. Free Androgen Index

Ovarian fibromas/thecomas are uncommon

Polycystic Ovary Syndrome

GONADOTROPIN BINDING SITES IN HUMAN POSTMENOPAUSAL OVARIES*

A rare case of pure Sertoli Cell Tumour of ovary in a woman with Posthysterectomy status

clinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome

ComprehensivePLUS Hormone Profile with hgh

Ovarian stromal hyperplasia and ovarian vein steroid levels in relation to endometrioid endometrial cancer

MULTILOCULAR PURE LEYDIG CELL TUMOR OF OVARY, FALLOPIAN TUBE, AND EXTRAOVARIAN SOFT TISSUE

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of

Difference Between PCOS and Endometriosis

Metabolic changes in menopausal transition

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

Case Scenario 1: Thyroid

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

Reproductive Hormones

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Diagnosi, inquadramento clinico e chirurgia

Physiology of Male Reproductive System

ADRENOCORTICOTROPIN (ACTH) Hormone made by the pituitary gland that stimulates production of adrenal hormones.

Hormonal Control of Human Reproduction

One Day Hormone Check

Hyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)

BIOSYNTHESIS OF STEROID HORMONES

Ovarian Tumors. Andrea Hayes-Jordan MD FACS, FAAP Section Chief, Pediatric Surgery/Surgical Onc. UT MD Anderson Cancer Center

Prognostic factors in sex cord stromal tumors of the ovary

Synthesis of sex steroids

Testosterone ELISA. Catalog No (96 Tests) For Research Use Only. Not for use in Diagnostic Procedures.

GONADAL FUNCTION: An Overview

Bilateral Ovarian Leiomyoma in Postmenopausal Women: A Case Report MK Eken, T Senol, EI Kaygusuz, T Erekul, E Cogendez, R Karakus, A Karateke ABSTRACT

Therapeutic Cohort Results

Overview of Reproductive Endocrinology

Improving treatment strategies in ovarian cancer: Towards individualized patient care van Meurs, H.S.

One of the commonest gynecological cancers,especially in white Americans.

OVARIES. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L13 Dr: Ali Eltayb.

Gynaecological Malignancies

Hirsutism: Diagnosis and Treatment. Roger A. Lobo M.D. Columbia University

Therapeutic Cohort Results

Hormone Balance - Female Report SAMPLE. result graph based on Luteal Phase. result graph based on Luteal Phase

UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE

FLASH CARDS. Kalat s Book Chapter 11 Alphabetical

The relative frequency and histopathological patterns of ovarian lesions: study of 116 cases

Ovarian Stromal Tumors: A Rare Cause of Postmenopausal Virilization. May Uyking-Naranjo and Roberto Mirasol

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule

8605 SW Creekside Place Beaverton, OR Phone: Fax: Samples Collected. Samples Received 06/21/2017

Estrogens and progestogens

Reproductive. Estradiol Analyte Information

Female androgen profiles by MS for PCOS patients. CS Ho APCCMS 2010, Hong Kong 14 January 2010

Pathology of Ovarian Tumours. Dr. Jyothi Ranganathan MD ( Path) AFMC Pune PDCC (Cytopathology) PGI Chandigarh

Two important cells in female are the theca cells and the granulose cells. Granulosa cells are affected by the two gonadotropin hormones; FSH and LH.

Polycystic Ovary Syndrome

Unexpected Gynecologic Findings at Laparotomy. Susan A. Davidson, MD University of Colorado, Denver School of Medicine

Labrix Clinical Services, Inc.

UTERINE LESIONS ASSOCIATED WITH FIBROMYOMA*

Therapeutic Cohort Results

Ph.D. THESIS ENDOMETRIAL HYPERPLASIAS IN PERIMENOPAUSE SUMMARY

Mousa. Najat kayed &Renad Al-Awamleh. Nizar Alkhlaifat

12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman

RENAL CELL CARCINOMA 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseud

Hitting the High Points Gynecologic Oncology Review

Indications for Surgical Removal of Adrenal Glands

!! 2 to 3% of All New Visceral Cancers.!! Peak Incidence is 6th Decade!! M:F = 2:1

Reproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands

ENDOCRINOLOGY 3. R. A. Benacka, MD, PhD, prof. Department of Pathophysiology Medical faculty, Safarik University, Košice

MEIG'S SYNDROME -A CASE REPORT

Case Report Metastatic Malignant Ovarian Steroid Cell Tumor: A Case Report and Review of the Literature

Diseases of the breast (1 of 2)

Histopathological Study of Spectrum of Lesions Seen in Surgically Resected Specimens of Fallopian Tube

3 cell types in the normal ovary

A case of extremely rare ovarian tumor: Primary ovarian adenomyoma

Genetic Variant of Luteinizing Hormone: Impact on Gonadal Steroid Sex Hormones in Women

Transcription:

Virilization and Enlarged Ovaries in a Postmenopausal Woman Rutgers University has made this article freely available. Please share how this access benefits you. Your story matters. [https://rucore.libraries.rutgers.edu/rutgers-lib/52404/story/] This work is an ACCEPTED MANUSCRIPT (AM) This is the author's manuscript for a work that has been accepted for publication. Changes resulting from the publishing process, such as copyediting, final layout, and pagination, may not be reflected in this document. The publisher takes permanent responsibility for the work. Content and layout follow publisher's submission requirements. Citation for this version and the definitive version are shown below. Citation to Publisher Version: Guerrero, Jessenia, Marcus, Jenna Z. & Heller, Debra. (2017). Virilization and Enlarged Ovaries in a Postmenopausal Woman. International Journal of Surgical Pathology. http://dx.doi.org/10.1177/1066896917713134 Citation to this Version: Guerrero, Jessenia, Marcus, Jenna Z. & Heller, Debra. (2017). Virilization and Enlarged Ovaries in a Postmenopausal Woman. International Journal of Surgical Pathology. Retrieved from http://dx.doi.org/doi:10.7282/t3125wcp Terms of Use: Copyright for scholarly resources published in RUcore is retained by the copyright holder. By virtue of its appearance in this open access medium, you are free to use this resource, with proper attribution, in educational and other non-commercial settings. Other uses, such as reproduction or republication, may require the permission of the copyright holder. Article begins on next page SOAR is a service of RUcore, the Rutgers University Community Repository RUcore is developed and maintained by Rutgers University Libraries

Virilization and Enlarged Ovaries in a Postmenopausal Woman Abstract: A patient with postmenopausal bleeding and virilization was found to have bilaterally enlarged ovaries with a yellow cut surface. Histology revealed cortical stromal hyperplasia with stromal hyperthecosis. This hyperplastic condition should not be mistaken for an ovarian neoplasm. Key words: Ovary, ovarian neoplasms, virilization

Introduction Postmenopausal women who present with clinical manifestations of hyperandrogenism are often presumed to have an androgen-secreting tumor, particularly if there is ovarian enlargement. Gross findings in the ovaries can help exclude an androgen-secreting ovarian tumor and histologic findings can confirm the gross findings. Case A 64 year old woman with abnormal hair growth, male pattern baldness, clitorimegaly and postmenopausal bleeding presented to the clinic for evaluation of a possible hormone secreting tumor. Pre-operative work-up revealed bilateral ovarian enlargement, measuring 4 cm in greatest dimension, without evidence of an ovarian or adrenal tumor. She was taken to the operating room and underwent a total hysterectomy with bilateral salpingo-oophorectomy. On gross pathologic examination the ovaries were firm with a smooth surface and prominent yellow/tan cut surfaces (Figure 1). No masses or lesions were noted grossly. Microscopically, cortical stromal hyperplasia with stromal hyperthecosis (Figure 2) was seen. Uterine findings were significant for an atrophic endometrium as well as few intramural leiomyomata. Comment In menopause, the proportion of androstenedione, a weak androgen, to estrogen production shifts in the ovaries(1), which often leads to mild increase in facial hair. When true signs of virilization are apparent, clinicians often assume that a masculinizing tumor is present, particularly if the ovaries or adrenals are enlarged. The most common considerations with ovarian enlargement are Sertoli-Leydig tumor and steroid cell tumor. Ovarian cortical stromal hyperplasia is a hyperplastic condition, not a neoplastic one. Its bilaterality is a clue to the fact that it is a hyperplasia, unlike Sertoli-Leydig tumor and steroid cell tumor which tend to be unilateral and larger in size. Cortical stromal hyperplasia should also be considered when the ovaries show a lack of circumscribed mass, and diffuse yellow coloration with mild enlargement. Cortical stromal hyperplasia can occur in postmenopausal women, and is also seen in polycystic ovarian disease. Histologic diagnosis confirms the clinical diagnosis. Cortical stromal hyperplasia displays an increase in hypercellular ovarian stroma in a nodular configuration. Stromal hyperthecosis often accompanies the cortical stromal hyperplasia, showing nests of luteinized stromal cells throughout the ovarian stroma 2. In contrast, Sertoli-Leydig tumor has a variable histology consisting of Sertoli, Leydig and fibroblast cells. Steroid cell tumor has nests of cells similar to stromal hyperthecosis, however, these cells would be diffuse, comprising the entire lesion. Patients with cortical stromal hyperplasia secrete increased androstenedione, leading to virilization. Aromatization of the androstenedione to estrone in peripheral adipose tissue can lead to hyperestrogenism as well, which is

the likely pathophysiology of her postmenopausal bleeding. An awareness of this condition is necessary to avoid overdiagnosis of a masculinizing neoplasm.

Legends: Figure 1- Ovaries showing yellow cut surfaces Fig 2-Stromal hyperthecosis. Nests of luteinized stromal cells are seen within the hyperplastic ovarian stroma(arrow and inset).

References Markopoulos, MC, Kassi E, Alexandraki KI, Mastorakos G, Kaltsas G. Management of Endocrine Disease: Hyperandrogenism After Menopause. Eur J Endocrinol2015;172:R79-R91. Brown DL, Henrichsen TL, Clayton AC, Hudson SB, Coddington CC III, Vella A. Ovarian stromal hyperthecosis: sonographic features and histologic associations. J Ultrasound Med. 2009;28:587 593.